WH van Gilst

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries

J. De Sutter, P. Woudstra, P. van der Harst, 2021, medRxiv.

Heart Failure after Myocardial Infarction—Benefit beyond Hemoglobin from Erythropoietin Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats with Heart Failure after Myocardial Infarction

D. J. Veldhuisen, R. Henning, A. Voors, 2005 .